Immunoproteasome inhibition attenuates experimental psoriasis

INTRODUCTION: Psoriasis is an autoimmune skin disease associated with multiple comorbidities. The immunoproteasome is a special form of the proteasome expressed in cells of hematopoietic origin. METHODS: The therapeutic use of ONX 0914, a selective inhibitor of the immunoproteasome, was investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: del Rio Oliva, Marta, Mellett, Mark, Basler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798438/
https://www.ncbi.nlm.nih.gov/pubmed/36591277
http://dx.doi.org/10.3389/fimmu.2022.1075615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798438/
https://www.ncbi.nlm.nih.gov/pubmed/36591277
http://dx.doi.org/10.3389/fimmu.2022.1075615

Ejemplares similares